von Willebrand Factor Antibody / vWF

NSJ Bioreagents
Product Code: NSJ-V2929
Product Group: Primary Antibodies
Supplier: NSJ Bioreagents
CodeSizePrice
NSJ-V2929-20UG20 ug£264.00
Quantity:
NSJ-V2929-100UG100 ug£534.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: Mouse IgG1, kappa
Antibody Clonality: Monoclonal
Antibody Clone: IIIE2.34
Regulatory Status: RUO
Target Species: Human
Application: Immunohistochemistry- Paraffin Embedded (IHC-P)
Storage:
Store the anti-vWF antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Images

1 / 2
IHC: Formalin-fixed, paraffin-embedded human tonsil stained with anti-vWF antibody (clone IIIE2.34).~
2 / 2
IHC staining of FFPE human tonsil with anti-vWF antibody (clone IIIE2.34). HIER: boil tissue sections in pH 9 10mM Tris with 1mM EDTA f

IHC: Formalin-fixed, paraffin-embedded human tonsil stained with anti-vWF antibody (clone IIIE2.34).~
IHC staining of FFPE human tonsil with anti-vWF antibody (clone IIIE2.34). HIER: boil tissue sections in pH 9 10mM Tris with 1mM EDTA f

Further Information

Application Details :
Immunohistochemistry (FFPE): 1-2ug/ml for 30 min at RT
Application Note:
Optimal dilution of the anti-vWF antibody should be determined by the researcher.

1. Staining of formalin-fixed tissues requires boiling tissue sections in pH 9 10mM Tris with 1mM EDTA for 10-20 min followed by cooling at RT for 20 min.

Description:
von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen.
Format :
Purified
Formulation :
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide
Immunogen:
A recombinant human protein fragment spanning aa 845-949 was used as the immunogen for the anti-vWF antibody.
Limitation:
This anti-vWF antibody is available for research use only.
Localization:
Cytoplasmic
Purity:
Protein G affinity chromatography
Species Reactivity :
Human
Uniprot #:
P04275